Results 131 to 140 of about 66,208 (273)

Mixed Invasive Aspergillus–Mucorales Pulmonary Coinfection in a Diabetic Patient: An Uncommon Dual Fungal Pneumonia and Literature Review

Respirology Case Reports, Volume 14, Issue 10, October 2026.
Our case describes a rare lung co‐infection caused by Aspergillus and Mucorales in a 61‐year‐old man with uncontrolled diabetes and chronic kidney disease. The diagnosis was made by BAL PCR and biopsy. Despite antifungal treatment, the patient worsened and died.
Vinay Venugopal, Saurabh Karmakar, Abdul Raouf Wani, Akshita Gupta, Gaurav Kumar Singh, Vijay Kumar, Shubhendu Mishra, Alpana Srivastava   +7 more
wiley   +1 more source

A Prospective Observational Study Evaluating the PRogression Of BronchiEctasis in COPD Patients - Results from the PROBE - COPD Study

International Journal of COPD
Rajesh Venkitakrishnan,1 Athulya Sudheendranath,2 Anand Vijay,1 Divya Ramachandran,1 Melcy Cleetus,1 Hasha Thankam Somson,1 Susan John3 1Department of Pulmonary Medicine, Rajagiri Hospital, Aluva, Kochi, Kerala, India; 2Department of Pulmonary Medicine ...
Venkitakrishnan R, Sudheendranath A, Vijay A, Ramachandran D, Cleetus M, Somson HT, John S   +6 more
doaj  

Associations of Serum CIRP and CXCL5 With Prognosis and Neutrophil Extracellular Traps in Pediatric Mycoplasma pneumoniae Pneumonia

The Clinical Respiratory Journal, Volume 20, Issue 10, October 2026.
This study investigated serum levels of cold‐inducible RNA‐binding protein (CIRP) and C‐X‐C motif chemokine ligand 5 (CXCL5) in 485 children with Mycoplasma pneumoniae pneumonia. Elevated levels of both biomarkers were independently associated with poor prognosis and positively correlated with neutrophil extracellular trap markers, suggesting their ...
Litao Wan, Bolin Liu, Ning Xie, Jianhua Li, Ting Su, Liyan Zhang, Xiaohua Wang, Shiding Gao   +7 more
wiley   +1 more source

The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study

Respiratory Research
Background Airflow obstruction is a hallmark of disease severity and prognosis in bronchiectasis. The relationship between lung microbiota, airway inflammation, and outcomes in bronchiectasis with fixed airflow obstruction (FAO) remains unclear.
Yen-Fu Chen, Hsin-Han Hou, Ning Chien, Kai-Zen Lu, Chieh-Hua Lin, Yu-Chieh Liao, Kuo-Lung Lor, Jung-Yien Chien, Chung-Ming Chen, Chung-Yu Chen, Shih-Lung Cheng, Hao-Chien Wang, Po-Ren Hsueh, Chong-Jen Yu   +13 more
doaj   +1 more source

Biomarkers in bronchiectasis

European Respiratory Review
Bronchiectasis is a heterogeneous disease with multiple aetiologies and diverse clinical features. There is a general consensus that optimal treatment requires precision medicine approaches focused on specific treatable disease characteristics, known as treatable traits.
Johnson, Emma, Long, Merete B., Chalmers, James D.   +2 more
openaire   +4 more sources

Selective MicroRNA Dysregulation in IPF‐Derived Mesenchymal Stromal Cells Suggests Restricted Regulatory Remodeling

The FASEB Journal, Volume 40, Issue 18, 30 September 2026.
The schematic workflow illustrates next‐generation sequencing of lung‐derived mesenchymal stromal cells (MSCs) from IPF patients and controls. Rather than broad epigenetic reprogramming, IPF‐MSCs exhibit a remarkably restricted down‐regulation of only three critical microRNAs: hsa‐miR‐373‐3p, hsa‐miR‐486‐5p, and hsa‐miR‐449a.
Mariangela Di Vincenzo, Federico Mei, Paride Cavina, Francesca Gonnelli, Martina Bonifazi, Monia Orciani   +5 more
wiley   +1 more source

Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study

Respiratory Research
Background Microbial infection and colonization are frequently associated with disease progression and poor clinical outcomes in bronchiectasis. Identification of pathogen spectrum is crucial for precision treatment at exacerbation of bronchiectasis ...
Jie-lin Duan, Cai-yun Li, Ying Jiang, Chao Liu, Pan-rui Huang, Li-fen Gao, Wei-jie Guan, Lin-Ling Cheng   +7 more
doaj   +1 more source

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

Pediatric Blood &Cancer, Volume 73, Issue 9, September 2026.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar, Karen Thibaudeau, Mary Mathias, Heather McDaniel, Madlen Reschke, Klaus Tenbrock, Joseph M. Parker, Amy Shapiro   +7 more
wiley   +1 more source

Reversible bronchiectasis [PDF]

Thorax, 2021
Chuan Tai Foo, Sumit Karia, Jurgen Herre
openaire   +2 more sources

Marked Long‐Term Improvement in Lung Function in Melanoma Differentiation–Associated Protein 5 Antibody–Positive Dermatomyositis Patients: Experience of a Single‐Center Longitudinal Cohort in North America

Arthritis Care &Research, Volume 78, Issue 9, Page 1112-1122, September 2026.
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation–associated protein 5 (MDA5) antibody–associated dermatomyositis (DM). Methods Thirty patients with MDA5 antibody–associated DM were identified in a single‐center longitudinal cohort of 352
Jenice X. Cheah, Sangmee S. Bae, Tiffany De Leon, Yuna Lee, Rong Guo, David Elashoff, Jennifer Wang, Ani Shahbazian, Christina Charles‐Schoeman   +8 more
wiley   +1 more source